Treating addiction: perspectives from EEG and imaging studies on psychedelics
Despite evidence of obvious benefits, social and political pressure began to effectively ban experimental research into psychedelic drugs in the late 1960s. Through the 1990s, there was a little resurgence of interest in psychedelic substances; however, the turn of the century, and particularly the last ten years, has seen a resurgence of interest in psychedelic substances (eg, LSD, ayahuasca, psilocybin). This article addresses EEG and brain imaging experiments that have been performed to determine the impact of psychedelics on the brain. In addition, evidence of the use of psychedelics as an adjunct therapy for a variety of psychological and addictive conditions is reviewed here. Psychedelics, in particular, tend to be effective in the treatment of depression.